Dr. Reddy's Laboratories Limited logo
Dr. Reddy's Laboratories Limited RDY
$ 11.55 0.17%
report update icon

Quarterly report 2025-Q4
added 09-14-2026

Dr. Reddy's Laboratories Limited Historical Prices | RDY

Annual Historical Prices Dr. Reddy's Laboratories Limited

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
14.7 13.9 11.2 11.1 65.4 71 40.1 37 36.5 43.7 44.5 48.2 38.9 31.4 27.5

All numbers in INR currency

Indicator range from annual reports

Maximum Minimum Average
71 11.1 35.7

Historical Prices of other stocks in the Biotechnology industry

Issuer Historical Prices Price % 24h Market Cap Country
AbbVie AbbVie
ABBV
226 $ 263.04 0.49 % $ 465 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
3.22 $ 11.41 2.15 % $ 3.41 B canadaCanada
Aclaris Therapeutics Aclaris Therapeutics
ACRS
3.14 $ 5.53 6.02 % $ 678 M usaUSA
ADC Therapeutics SA ADC Therapeutics SA
ADCT
1.09 $ 1.09 3.74 % $ 139 M schweizSchweiz
Amryt Pharma plc Amryt Pharma plc
AMYT
10.8 - - $ 621 M britainBritain
Evelo Biosciences Evelo Biosciences
EVLO
0.31 - -14.46 % $ 27.9 M usaUSA
Allakos Allakos
ALLK
1.31 - - $ 28.6 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
2.44 - - $ 231 M usaUSA
Clovis Oncology Clovis Oncology
CLVS
2.04 - -7.23 % $ 13 M usaUSA
Chimerix Chimerix
CMRX
1.17 - - $ 756 M usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
3.03 - - $ 401 M usaUSA
ADMA Biologics ADMA Biologics
ADMA
15.9 $ 8.61 0.16 % $ 2.05 B usaUSA
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
2.11 - -9.21 % $ 2.55 M usaUSA
89bio 89bio
ETNB
9.32 - - $ 1.55 B usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
4.4 - - $ 384 M britainBritain
Fusion Pharmaceuticals Fusion Pharmaceuticals
FUSN
21.1 - - $ 1.41 B canadaCanada
Guardion Health Sciences Guardion Health Sciences
GHSI
6.33 - -0.31 % $ 3.64 M usaUSA
Genocea Biosciences Genocea Biosciences
GNCA
1.06 - -15.0 % $ 3.04 M usaUSA
Gritstone Oncology Gritstone Oncology
GRTS
2.39 - 0.42 % $ 213 M usaUSA
G1 Therapeutics G1 Therapeutics
GTHX
3.35 - - $ 370 M usaUSA
Harpoon Therapeutics Harpoon Therapeutics
HARP
0.65 - - $ 763 M usaUSA
Humanigen Humanigen
HGEN
0.14 - -81.12 % $ 4.28 M usaUSA
HOOKIPA Pharma HOOKIPA Pharma
HOOK
0.71 - -6.92 % $ 79.4 M usaUSA
Intercept Pharmaceuticals Intercept Pharmaceuticals
ICPT
20.9 - - $ 643 M usaUSA
IGM Biosciences IGM Biosciences
IGMS
1.4 - - $ 76.9 M usaUSA
IMV IMV
IMV
0.82 - - $ 13.1 M canadaCanada
Intra-Cellular Therapies Intra-Cellular Therapies
ITCI
129 - - $ 13.6 B usaUSA
Kinnate Biopharma Kinnate Biopharma
KNTE
2.66 - - $ 123 M usaUSA
Chinook Therapeutics Chinook Therapeutics
KDNY
21.6 - - $ 2.6 B usaUSA
Kaleido Biosciences Kaleido Biosciences
KLDO
1.76 - -3.69 % $ 12.4 M usaUSA
Kronos Bio Kronos Bio
KRON
1.2 - 1.49 % $ 50.8 M usaUSA
Karuna Therapeutics Karuna Therapeutics
KRTX
319 - - $ 12.2 B usaUSA
Landos Biopharma Landos Biopharma
LABP
7.67 - 0.58 % $ 144 M usaUSA
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
4.63 - - $ 154 M usaUSA
LogicBio Therapeutics LogicBio Therapeutics
LOGC
2.31 - - $ 229 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
3.02 - - $ 35.3 M usaUSA
Merrimack Pharmaceuticals Merrimack Pharmaceuticals
MACK
14.8 - - $ 216 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
0.66 - - $ 23.9 M usaUSA
Mirati Therapeutics Mirati Therapeutics
MRTX
45.6 - - $ 3.3 B usaUSA
NexImmune NexImmune
NEXI
3.47 - 70.13 % $ 4.12 M usaUSA
9 Meters Biopharma 9 Meters Biopharma
NMTR
1.35 - -42.97 % $ 1.05 M usaUSA
InVivo Therapeutics Holdings Corp. InVivo Therapeutics Holdings Corp.
NVIV
2.05 - -37.48 % $ 476 K usaUSA
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation
NYMX
0.2 - -19.68 % $ 18.4 M canadaCanada
ObsEva SA ObsEva SA
OBSV
1.99 - -15.52 % $ 10.5 M schweizSchweiz
Oncorus Oncorus
ONCR
0.33 - -8.54 % $ 3.19 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
0.45 - 31.87 % $ 1.61 M usaUSA
Oncternal Therapeutics Oncternal Therapeutics
ONCT
9.29 - -24.12 % $ 1.56 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
26.2 - - $ 109 M usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
5.25 - 1.02 % $ 90.8 M britainBritain